Accessibility / Report Error
(Updated: 2024/08/22)

ABOUT THE JOURNAL

Brief Background

 

Jornal de Pediatria is a bimonthly, on-line only publication of the Brazilian Society of Pediatrics (Sociedade Brasileira de Pediatria, SBP), having been published without interruption since 1934 and only in English. Jornal de Pediatria aims at improving the standards of pediatrics and of the healthcare provided for children and adolescents, as well to foster debate about health.

The title should be abbreviated as J. Pediatr. (Rio J.), which must be used in references, footnotes and bibliographic captions.

 

 

Open Science Compliance

 

Jornal de Pediatria is a Gold Open Access journal.

Manuscript submission is continuous and completely free. Access, reading, downloading, citing, copying, distributing, printing, etc. full published manuscripts are also free, without prior permission from the editors or authors. Correct references to the journal must be mentioned in the citing material.

During the submission, authors must inform about the study's compliance with Open Science communication practices by filling in the Form available here.  

It is recommended that all content underlying the text of the manuscript be made available either during the submission or in open access repositories. The cited data must be referenced in the article together with the bibliographic references, indicating the location address of the file/s in the repository.

In the case of data restricted by legal and/or ethical issues, the reason for the restriction and the contact responsible for providing the information must be informed.

 

 

Ethics in Publication

 

Jornal de Pediatria is rigorously committed to good practices in scientific publication and follows international standards in resolving ethical issues in publication. The journal adheres to the guidelines of COPE, Equator Network, ICMJE and the Good Practice Guide for Strengthening Ethics in Scientific Publication for the analysis of possible cases of misconduct in publication, including guidelines on data presentation, authorship, conflicts of interest, privacy and consent.

 

 

Focus and Scope

 

A bimonthly publication of the Brazilian Society of Pediatrics (SBP), the Jornal de Pediatria publishes original articles and review articles, covering the various areas of pediatrics.

 

 

Digital Preservation

 

This journal follows the standards defined in the SciELO Program's Digital Preservation Policy.

 

 

Indexing Sources

   

 

Bibliographic Journal Information

 
  • Journal title: Jornal de Pediatria
  • Short title: J Pediatr (Rio J).
  • Published by: Elsevier
  • Frequency: Bi-monthly
  • Publication mode: Regular
  • Year when the journal was created: 1934
 

 

Websites and Social Media

   

 

EDITORIAL POLICY

Preprints

 

Jornal de Pediatria accepts manuscripts that have been deposited in preprint servers, such as  Preprints, SciELO Preprints and EmeRI, bioRxiv and medRxiv, provided that the authors inform the following details: title, authors, name of the repository where it was published, date of publication, DOI, possible conflicts of interest, in addition to sending the Open Science Compliance Form.

 

 

Peer Review Process

 

This journal adopts the double-blind peer review process, in which authors and reviewers do not know each other's identity. Therefore, the files with the identification of the authors must be submitted separately from the other files. The process includes the following steps:

- Screening by the editorial assistance: upon receipt, the article is checked regarding the format requested by the journal (written in English, the number of attachments, if original or review article, references in Vancouver format, etc.). Otherwise, the manuscript is returned for adjustments. If the article complies with the standards, it is assigned to the Editor-in-Chief or Associate Editor according to the topic of the article.

- Initial Screening by the Associate Editor assigned according to the subject area of the article: the manuscript is checked if complies with the scope and quality standards of the journal. Manuscripts that do not meet these criteria are rejected in the initial phase. Otherwise, the manuscript is sent to be assessed by at least two peer reviewers.

- Double-blind peer review: reviewers assess the manuscript anonymously and submit their opinions through the system.  In cases of preprint, it is not possible to guarantee the anonymity of the authors. Based on these opinions, the Associate Editor makes a recommendation for reject, review or accept the article.

- Editor's evaluation with the reviewers' opinions: The decision of the Associate Editor on the first version of the article is sent to the authors: reject or review. If the opinions indicate that the article has methodological gaps that would not be remedied in a new version, the article is rejected. If the manuscript receives a review recommendation, authors have up to 30 days to send the revised version of the article, explaining and pointing out the changes made. New versions of the article may be requested. If the authors do not comply with the requests made by the reviewers and the editor, the article may be rejected. This decision is communicated to the Editor-in-Chief who can ratify or refute this decision.

- Acceptance of the article: As soon as the Associate Editor accepts the article, the authors will be notified of the decision by e-mail with the instructions for the payment of the publication fee. Upon completion of this process, the article will be submitted for the PDF production process.

- PDF approval and publication: Authors will receive an email for approval of the final PDF file of the article. Corrections requested at this stage of the process should be limited to typographical errors and should not involve changes in the content of the study or in the list of authors.  Authors must return the approved version by email within 48 hours of receiving the message. After the approval, the article will be submitted for publication.

In line with open science practices, the journal offers authors and reviewers the option of mutual opening up the peer review process, with or without identifying their names. Authorization to disclose their names can be given by the authors when submitting the article and by the reviewers when accepting the invitation. In the event of publication of the evaluations on which the decision to publish the article was based, they may be edited by the journal's editorial board. This option is subject to mutual agreement between authors and reviewers and must be discussed and agreed between authors, reviewers, and editors and communicated to the journal during the submission process. Adhering to this option is voluntary and aims to promote a transparent assessment environment, respecting confidentiality preferences. The name of the Associate Editor responsible for evaluating the manuscript is published with the article.

 

 

Open Data

 

In order to promote transparency, when submitting the article, we encourage authors to declare the availability of their data, be it analysis datasets, instruments, statistical analysis scripts, scripts and additional materials, made available in open online repositories, such as SciELO Data, Zenodo, Figshare, OSF, or Mendeley Data, if they cannot be published in the article itself. This information must be clearly indicated in the manuscript.  Therefore, we request that all datasets associated with the submitted manuscripts be accompanied by the Open Science Compliance Form.

If the data is not available for access or is not suitable for publication, there will be an opportunity to describe the reason during the submission process, stating, for example, that the research data is confidential. The statement will appear with the published article.

 

 

Fees

 

Jornal de Pediatria does not charge a fee for submission, evaluation and review of the articles. After the article is accepted, a processing fee for publication is charged.

There is a discount on the fee if any of the authors is associated with the Brazilian Society of Pediatrics.

Fees:
If any of the authors is associated with BSP: R$1,500 per accepted manuscript.
If none of the authors is associated with BSP: R$2,500 per accepted manuscript. Foreign authors, not living in Brazil: U$1,500 per accepted manuscript.
The accepted article will only be published after we receive the payment proof of the publication fee.

Deadline: After being informed of the acceptance in the journal, the authors have up to 30 days to send the proof of payment and the payer's data (full name, CPF or CNPJ, full address with zip code and email). After our confirmation, the article is then sent for editing and publication. Payment made after this period may result in a change in the journal's schedule.

Finance statement: For the issuance of any document attesting the payment, please contact us with the authors' full name, full address with zip code, and email of the payer. For more information and other possibilities of payment methods, please contact us.

 

 

Ethics and Misconduct, Correction and Retraction Policy

 

Each manuscript submitted will be checked by the originality detection service CrossCheck.

In case of suspicion on ethical misconduct, the Editor-in-Chief will evaluate the situation. Corrections or clarifications may be published if necessary. Cases not listed here will be resolved by the Editor-in-Chief and Associated Editors.

 

 

Policy on Conflict of Interest

 

The conflicts of interest may be of a personal, commercial, political, academic and/or financial nature. Conflicts of interest may occur when authors, reviewers or editors have interests that may influence the preparation or evaluation of manuscripts. When submitting the manuscript, authors are responsible for recognizing and disclosing financial or other conflicts that may have influenced the research. If there is even a potential conflict of interest, the author(s) must inform it in their document signed and attached through the submission platform.

 

 

Adoption of Similarity Software

 

Each manuscript submitted will be checked by the originality detection service CrossCheck.

The use of Chatbots or other artificial intelligences must be stated in the article submission. These technologies should not be listed as authors and should be used to check grammar, spelling, references, etc. The statement will be published with the article.

 

 

Gender and Sex Issues

 

The editorial team of the Jornal de Pediatria, in addition to the authors who publish in the journal, must always observe the guidelines on Sex and Gender Equity in Research (SAGER). The SAGER guidelines comprise a set of guidelines for the reporting of sex and gender information in study design, data analysis, outcome reporting and research interpretation. In addition, the Jornal de Pediatria observes the gender equity policy in the formation of its Editorial Board.

 

 

Ethics Committee

 

Studies involving patients or volunteers require ethics committee approval and informed consent, which must be informed in the text of the article. It must be included a statement with the approval by the research ethics committee (or equivalent) of the institution in which the study was carried out.

 

 

Copyright

 

Authors of articles published by Jornal de Pediatria retain the copyright of their works, licensing them under the Creative Commons Attribution CC BY 4.0 license, which allows the articles to be reused and distributed without restriction, provided that the original work is correctly cited, and the authors grant the journal the right of first publication.

 

 

Intellectual Property and Terms of Use

 

Responsibility of the website:

The copyright terms applied to the content published must be clearly stated and differentiated from the copyright terms applied to the website itself.

Authors Responsibility:

The author is responsible for obtaining authorizations (from persons, institutions, other authors and/or publishers) on copyright for the use of images, tables, figures, methods or other elements used in the manuscript to be published.
All journal content and articles published by Jornal de Pediatria, except where otherwise specified, are licensed under the Creative Commons Attribution (CC BY) 4.0 license.

Authors of articles published by Jornal de Pediatria retain the copyright of their works, licensing them under the Creative Commons Attribution CC BY 4.0 license, which allows articles to be reused and distributed without restriction, as long as the original work is correctly cited.

Jornal de Pediatria encourages authors to self-archive their accepted manuscripts, publishing them in personal blogs, institutional repositories and academic social media, as well as posting them on their personal social media, provided that the full citation to the journal's website version is included.

 

 

Sponsors and Promotion Agencies

 

Brazilian Society of Pediatrics

 

EDITORIAL BOARD

 

Editor-in-Chief

   

 

Associated Editors

   

 

Editorial Board

 
  • Alexandre Tellechea Rotta, Duke University Medical Center, Division of Pediatric Critical Care Medicine, Durham, North Carolina/NC, United States, Orcid: 0000-0002-4406-2276, e-mail: alexandre.rotta@duke.edu
  • Andrew Bush, National Heart and Lung Institute, Royal Brompton & Harefield NHS Foundation Trust, London, United Kingdom, Orcid: 0000-0001-6756-9822, e-mail: a.bush@imperial.ac.uk
  • Antonio Condino Neto, Universidade de São Paulo (USP), Instituto de Ciências Biomédicas, São Paulo, SP, Brazil, Orcid: 0000-0002-1069-3117, Lattes: http://lattes.cnpq.br/5546433568874059, e-mail: antoniocondino@gmail.com
  • Asunción Mejias, The Ohio State University College of Medicine, Nationwide Children’s Hospital, Center for Vaccines & Immunity, Abigail Wexner Research Institute, Columbus, Ohio/OH, United States, Orcid: 0000-0002-5983-8006, e-mail: Asuncion.Mejias@nationwidechildrens.org
  • Bruce Kalman Rubin, Children's Hospital of Richmond, Virginia Commonwealth University, Richmond, Virginia/VA, United States, Orcid: 0000-0003-0876-4016, e-mail: bruce.rubin@vcuhealth.org; bkrubin@outlook.com
  • Eduardo Bancalari, University of Miami, Miller School of Medicine, Miami, Florida/FL, United States, Orcid: 0000-0002-1115-8845, e-mail: ebancalari@miami.edu
  • Jaderson Costa da Costa, Pontifícia Universidade Católica do Rio Grande do Sul (PUCRS), School of Medicine, Porto Alegre, Rio Grande do Sul/RS, Brazil, Orcid: 0000-0001-6776-1515, Lattes: http://lattes.cnpq.br/9962204158580009, e-mail: jcc@pucrs.br
  • Janet Englund, University of Washington, Seattle Children’s Hospital, Seattle, Washington/WA, United States, Orcid: 0000-0003-1134-4178, e-mail: janet.englund@seattlechildrens.org
  • Joseph A. Carcillo, UPMC Childrens' Hospital of Pittsburgh, Center for Critical Care Nephrology, Pittsburgh, Pensilvania/PA, United States, Orcid: 0000-0001-8920-4330, e-mail: carcilloja@ccm.upmc.edu
  • Krisa Page van Meurs, Stanford University School of Medicine, Neonatal ECMO and NeuroNIICU, Lucile Packard Children’s Hospital, Palo Alto, California/CA, United States, Orcid: 0000-0002-9242-1480, e-mail: vanmeurs@stanford.edu
  • Luciana Rodrigues Silva, Universidade Federal da Bahia, Faculdade de Medicina, Salvador, Bahia/BA, Brazil, Orcid: 0000-0003-2995-8581, Lattes: http://lattes.cnpq.br/9830220146602487, e-mail: lupe.ssa@uol.com.br
  • Mauro Batista de Morais, Universidade Federal de São Paulo (Unifesp), Escola Paulista de Medicina, São Paulo, SP, Brazil, Orcid: 0000-0003-4014-5549, Lattes: http://lattes.cnpq.br/5056114729141952, e-mail: maurobmorais@gmail.com
  • Namasivayam Ambalavanan, Virginia Walker Jones Chair in Neonatology, Division of Neonatology; University of Alabama, Departments of Pediatrics, and Cell, Developmental, and Integrative Biology, Birmingham, Alabama/AL, United States, Orcid: 0000-0003-0731-9092 , e-mail: ambal@uab.edu
  • Nelson Augusto Rosário Filho, Universidade Federal do Paraná (UFPR), Setor de Ciências da Saúde, Curitiba, Paraná/PR, Brazil, Orcid: 0000-0002-8550-8051, Lattes: http://lattes.cnpq.br/9586520484706376, e-mail: nelson.rosario@onda.com.br
  • Pablo J. Sanchez, Nationwide Children's Hospital, The Ohio State University College of Medicine, Center for Perinatal Research, The Abigail Wexner Research Institute, Columbus, Ohio/OH, United States, Orcid: 0000-0003-2437-1247, e-mail: pablo.sanchez@nationwidechildrens.org
  • Philip John Cooper, St George’s University of London, Institute of Infection and Immunity, London, United Kingdom; and Universidad Internacional del Ecuador, Escuela de Medicina, Quito, Ecuador, Orcid: 0000-0001-6122-3492, e-mail: pcooper@sgul.ac.uk
  • Richard Polin, Columbia University Medical Center, Department of Pediatrics, New York City, NY, United States, Orcid: 0000-0003-2846-2023, e-mail: rap32@cumc.columbia.edu
  • Ruth Guinsburg, Universidade Federal de São Paulo (Unifesp), Escola Paulista de Medicina, São Paulo, SP, Brazil, Orcid: 0000-0003-1967-9861, Lattes: http://lattes.cnpq.br/6286661930160341, E-mail: ruth.guinsburg@gmail.com
  • Salmo Raskin, Laboratório Genetika, Curitiba, Paraná/PR, Brazil; Comitê Científico de Genética, Sociedade Brasileira de Pediatria, Brazil, Orcid: 0000-0002-7191-0592, Lattes: http://lattes.cnpq.br/3144868954650115, e-mail: s.raskin@genetika.com.br
  • Shlomo Shinnar, Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, New York/NY, United States, Orcid: 0000-0001-6714-3960, e-mail: sshinnar@aol.com
  • Stefano Cianfarani, University of Rome ‘Tor Vergata', Department of Systems Medicine; 'Bambino Gesù' Children's Hospital, Diabetology & Growth Disorders Unit, Rome, Italy, Orcid: 0000-0002-2580-8781, e-mail: stefano.cianfarani@uniroma2.it; stefano.cianfarani@opbg.net
  • Stéphane Auvin, Université Paris-Cité, Robert-Debré University Hospital, Institut Universitaire de France, Robert-Debré Hospital, Paris, France, Orcid: 0000-0003-3874-9749, e-mail: stephane.auvin@aphp.fr
  • Thomas Michael O’Shea, University of North Carolina, Department of Pediatrics, Chapel Hill, North Carolina/NC, United States, Orcid: 0000-0001-6692-911X, e-mail: moshea52@email.unc.edu
  • Tina Quanbee Tan, Northwestern University Feinberg School of Medicine, Ann & Robert H. Lurie Children’s Hospital of Chicago, Chicago, Illinois/IL, United States, Orcid: 0000-0003-3902-9567, e-mail: titan@luriechildrens.org
  • Werther Brunow de Carvalho, University of São Paulo (USP), Faculty of Medicine, São Paulo, SP, Brazil, Orcid: 0000-0002-9164-616X, Lattes: http://lattes.cnpq.br/0981020175869536, e-mail: werther.brunow@hc.fm.usp.br
  • Yvan Vandenplas, KidZ Health Castle, UZ Brussel Hospital, Vrije Universiteit Brussel, Free University of Brussel, Brussels, Belgium, Orcid: 0000-0002-1862-8651,  e-mail: Yvan.Vandenplas@uzbrussel.be
 

 


INSTRUCTIONS TO AUTHORS

Types of Documents Accepted

 

Jornal de Pediatria accepts submissions of Original Articles, Review Articles and Letters to the Editor.

Original articles include reports on randomized and controlled trials, screening and diagnostic studies, and other descriptive and intervention studies, as well as records of basic research conducted with laboratory animals. Manuscripts in this category should not exceed 3,000 words (excluding title page, references and tables), 30 references and four tables and figures.

Review articles are meta-analysis, systematic or critical assessments of the literature concerning topics of clinical relevance, with emphasis on aspects such as cause and prevention of diseases, diagnosis, treatment, and prognosis. Review articles should not exceed 6,000 words (excluding title page, references and tables) and a minimum of 30 up-to-date references should be cited. Meta-analyses are included in this category. Please contact us to submit an outline or script to the Editorial Board before submitting the complete manuscript. Jornal de Pediatria also accepts to analyze unsolicited review articles. Jornal de Pediatria also accepts to analyze unsolicited review articles.

Letters to the editor must discuss or criticize articles previously published in Jornal de Pediatria. Letters should not exceed 1,000 words and six references. If possible, a response from the authors of the article to which the letter refers will be published along with the letter.

Editorials and comments refer to selected articles and are requested by the journal from experts in the field.

Visit http://www.equator-network.org/ for information on the guidelines to be followed in health research for this type of article.

 

 

Authors' Contribution

 

Each author is required to state their individual contribution to the article: all authors must have participated substantially in the research and/or preparation of the article, so that the role of each of the authors must be described:

(1) the conception and design of the study, data acquisition, or data analysis and interpretation,
(2) writing of the article or critical revision for important intellectual content,
(3) final approval of the version to be submitted.

Authors are expected to carefully consider the list and order of authors before submitting their manuscript and provide the definitive list of authors at the time of the original submission. Any addition, deletion or rearrangement of author names in the authorship list should be made only before the manuscript has been accepted and only if approved by the Editor-in-Chief. If the authors would like to make such a change, the Editor must receive the following from the corresponding author:

(a) the reason for the change in author list and
(b) written confirmation (e-mail, letter) from all authors that they agree with the addition, removal or rearrangement. The author(s) being added or removed must confirm this change.

The statement that all authors have approved the final article should be true and included in the disclosure.

 

 

Manuscript Preparation

 

Three files are required for the submission of an article: Author agreement, Title Page and Manuscript.

Author agreement: Form on Open Science Compliance or Cover Letter in which the authors declare that the article has not been previously published (except in the form of an abstract or as part of a published academic lecture or thesis); is not being evaluated for publication elsewhere; its publication has been approved by all authors and tacitly or explicitly by the responsible authorities where the study was carried out; and, if accepted, it will not be published elsewhere in the same form, in English or in any other language, including electronically, without the written consent of the copyright holder.

Title page (with author details): must contain the following information:

a) concise and informative title. Avoid unnecessary terms and abbreviations; also avoid references to the place and/or city where the study was carried out;
b) short title of not more than 50 characters including spaces to appear on the headers;
c) full names of the authors and ORCID. If any of the authors do not have this ID, they must register at https://orcid.org/register;
d) authors’ highest academic degree;
e) e-mail address of all authors;
if available, URL to the electronic curriculum vitae (“Curriculum Lattes” for Brazilian authors, ORCID etc.)
g) specific contribution of each author to the study;
h) statement of conflicts of interest (write “nothing to declare” or clearly disclose any financial or other interests which could cause embarrassment if revealed after the publication of the article);
i) institution or service with which the research is associated for indexation in the Index Medicus/MEDLINE;
j) author's name, address, telephone number and e-mail address of the corresponding author;
k) name, address, telephone number and e-mail of the author in charge of the pre-publication contact;
l) sources of financing, or name of institutions or companies supplying equipment and materials, if applicable;
m) word count of the main text, not including abstract, acknowledgments, references, tables and captions of figures;
n) word count of the abstract;
o) number of tables and figures.

Blind manuscript (no author details): The main body of the article (including references, figures, tables, and any acknowledgments) should not include any identification, such as the authors' names or affiliations. It is important that the file is saved in the original format. Use a single-column format. Keep the layout of the text as simple as possible. Highlights such as bold, italic, subscript, superscript, etc. can be used. When preparing tables, use only one grid for each table individually, not one grid for each row. If no grid is used, use the tab, not spaces, to align the columns. Note that the source files of the figures, tables, and graphs will be required, regardless of whether or not you embed them in the text.

Abstract:The abstract should briefly state the purpose of the research, the principal results and major conclusions. An abstract is often presented separately from the article, so references should be avoided, but if necessary, cite the author(s) and year(s). Non-standard or uncommon abbreviations should be avoided, but if essential they must be defined at their first mention in the abstract itself. The abstract should have no more than 250 words or 1,400 characters. Do not include words that could identify the institution or city where the study was performed, to facilitate blind review. The abstract should be structured as follows:

Abstract for original articles

Objective: State why the study was initiated and any initial hypotheses. Precisely define the main purpose of the study; only the most relevant secondary objectives should be listed.
Method: Describe the study design (if appropriate, state whether the study is randomized, blinded, prospective, etc.), setting (if appropriate, describe the level of care, i.e., primary, secondary or tertiary, private clinic or public institution, etc.), patients or participants (selection criteria, number of cases at the beginning and at the end of the study, etc.), interventions (include essential information, such as methods and duration of the study), and criteria used to measure the outcomes.
Results: Describe the most important findings, confidence intervals, and statistical significance of the findings. Conclusions: Only describe conclusions that reflect the purpose of the study and that are supported by your findings. Discuss possible applications of the findings, with equal emphasis on positive and negative findings that have similar scientific merit.

Abstract for Review Articles

Objective: Explain why the review was carried out, stating whether it focuses on a special factor, such as disease etiology, prevention, diagnosis, treatment or prognosis.
Sources: Describe all sources of information, defining databases and years researched. Briefly state the criteria used to select articles for review and to assess the quality of information.
Summary of the findings: State the main quantitative or qualitative findings.
Conclusions: State your conclusions and their clinical application, keeping generalizations within the scope of the topic under review.

Keywords:Immediately after the abstract, provide a maximum of 6 keywords, using American spelling and avoiding general and plural terms and multiple concepts (avoid, for example, 'and', 'of'). Use abbreviations sparsely. These keywords will be used for indexing purposes. Please use the terms listed in Medical Subject Headings (MeSH), available at http://www.nlm.nih.gov/mesh/meshhome.html. When suitable descriptors are not available, new terms may be used.

Abbreviations: All abbreviations must be explained at their first mention in the text. Non-standard abbreviations in the field of pediatrics must be defined in a footnote to be placed on the first page of the article. Avoid the use of abbreviations in the abstract; those that are unavoidable should be defined at their first mention.

Acknowledgements: Group acknowledgements in a separate section at the end of the article before references. List here those individuals who provided help during the research (e.g., providing language help, writing assistance or proofreading the article, etc.). Only individuals or institutions that contributed significantly to the study, but are not qualified for authorship, should be mentioned. Individuals cited in this section must agree in writing to the inclusion of their names, since readers may infer their endorsement of the conclusions of the study.
Funding sources:List funding sources in this standard way to facilitate compliance to funder's requirements.

Text:The main text in original articles should contain the following sections, indicated by a subtitle: Introduction, Methods, Results, and Discussion. The sections in review articles may vary depending on the topic.

Follow internationally accepted rules and conventions: use the international system (SI) of units. If other units are mentioned, please give their equivalent in SI.

Please submit math equations as editable text and not as images. Present simple formulae in line with normal text where possible and use the solidus (/) instead of a horizontal line for small fractional terms, e.g., X/Y. In principle, variables are to be presented in italics. Powers of e are often more conveniently denoted by exp. Consecutively number any equations to be displayed separately from the text (if explicitly referred to in the text).

Footnotes should not be used. Instead, incorporate the relevant information into the main text.

In the case of an original article, include a statement about the approval of the research by an institutional ethics committee. Studies involving patients or volunteers require ethics committee approval and informed consent, which must be informed in the text of the article. Relevant consents, permissions and releases must be obtained whenever an author wishes to include case details or other personal information or images of patients and any other individuals. Written consents must be retained by the author and copies of the consents or evidence that such consents have been obtained must be provided on request. Unless you have written permission from the patient (or, where applicable, the next of kin), personal details of any patient included in any part of the article and in any supplementary materials (including all illustrations and videos) must be removed before submission.

When submitting randomized controlled trials should be, authors must provide the CONSORT checklist accompanied by a flow diagram that illustrates the progress of patients through the trial, including recruitment, enrollment, randomization, withdrawal and completion, and a detailed description of the randomization procedure. The CONSORT checklist and flowchart template are available at http://www.consort-statement.org/.   

Registration in a public trials registry is a condition for publication of clinical trials in this journal in accordance with International Committee of Medical Journal Editors recommendations. Trials should be recorded at baseline or prior to patient enrollment. The clinical trial registration number should be included at the end of the abstract of the article. Purely observational studies (those in which the assignment of the medical intervention is not at the discretion of the investigator) will not require registration.

In line with the position of the International Committee of Medical Journal Editors, the journal will not consider results posted in the same clinical trials registry in which primary registration resides to be prior publication if the results posted are presented in the form of a brief structured (less than 500 words) abstract or table. However, disclosure of results in other circumstances (e.g., investor meetings) is discouraged and may prevent acceptance of the manuscript. Authors should fully disclose all posting in registries of results of the same or closely related work.

 

 

Article Submission Format

 

Title in English only: Concise and informative title. Avoid unnecessary terms and abbreviations; also avoid reference to the site and/or city where the research was carried out.

Short title: Title of not more than 50 characters including spaces to appear on the headers.

Authors:

1.     Full name of all authors (no abbreviations) and authors’ highest academic degree.
2.     Inform the full affiliation of all authors (Department/Unit, Institution/Organization, City, Country).
3.     Inform the official institution or service to which the research is linked for registration purposes in the Index Medicus/MEDLINE database, City, Country.
4.     E-mail address of each author.
5.     Inform the curriculum registered in the Lattes platform of CNPq (in case of Brazilian authors).
6.     Inform the ORCID registration number of all authors (mandatory as of January 2019).
7.     The specific contribution of each author to the study.

Conflict of interest: write “nothing to declare” or clearly disclose any financial or other interests which could cause embarrassment if revealed after the publication of the article.

Corresponding author: name, regular address, telephone and e-mail address

Funding source: institutions or suppliers of equipment and materials, when applicable.

Total text word count: Original articles cannot exceed 3,000 words and review articles cannot exceed 6,000 words, excluding abstract, acknowledgments, references, tables and figure captions.

Abstract: The abstract must have a maximum of 250 words. Please avoid the use of abbreviations and identifications.

Abstract for original articles: Objective, Methods, Results, Conclusions

Abstract for review articles: Objective, Sources, Summary of the findings, Conclusions

Keywords: Three to six: Keyword 1; Keyword 2; Keyword 3. Please use Medical Subject Headings (MeSH), available at http://www.nlm.nih.gov/mesh/meshhome.html.

In the case of an original article, include a statement informing that the research was approved by an institutional ethics committee.
In randomized controlled trials and clinical trials, authors must provide the CONSORT checklist accompanied by a flow diagram that illustrates the progress of patients through the trial. Registration in a public trials registry is a condition for publication of clinical trials in this journal in accordance with International Committee of Medical Journal Editors recommendations.

 

 

Digital Assets

 

The total number of tables and figures must not be greater than 4. The information contained in tables or figures must not be repeated in the text. If there are more than 4 attachments, please indicate which may be considered as supplementary material (to be made available only on our website if the article is accepted).

Tables
Tables must be submitted as editable text and not as an image and use vertical grids and shading in table cells. They can be placed next to the relevant text in the article, or on separate pages at the end. Tables should be numbered consecutively according to their order in the text.

Figures
Figures reproduced from other sources already published must indicate this condition in the notes, accompanied by a letter of permission from the rights holder. Photos should not allow patient identification.
The manipulation of images for the purpose of intent or fraud will be seen as scientific ethical abuse and will be treated accordingly. For graphic images, no specific feature within an image may be enhanced, obscured, moved, removed, or introduced. Adjustments of brightness, contrast, or color balance are acceptable if and as long as they do not obscure or eliminate any information present in the original.  Non-linear adjustments (e.g., changes to gamma settings) must be disclosed in the figure caption.

Formats
EPS (or PDF): Vector drawings, embed all used fonts.
TIFF (or JPEG): Color or grayscale photographs (halftones), keep to a minimum of 300 dpi.
TIFF (or JPEG): Bitmapped (pure black & white pixels) line drawings, keep to a minimum of 1000 dpi.
TIFF (or JPEG): Combinations bitmapped line/half-ton (color or grayscale), keep to a minimum of 500 dpi.

Captions
Make sure that each figure has a caption. Provide the captions separately, not attached to the figures. A caption should include a brief title (not in the figure itself) and a description of the illustration. Keep the text short in the illustrations themselves, but explain all symbols and abbreviations used.

 

 

Citations and References

 

Original articles must have no more than 30 references. Review articles must have a minimum of 30 up-to-date references. They must be numbered consecutively identified by Arabic numerals in square brackets [1]. Unpublished observations and personal communications should not be cited as references; they may be cited within the text, followed by the observations in parentheses “unpublished observation” or “personal communication.” References should follow the Vancouver style. Authors should consult Citing Medicine, The NLM Style Guide for Authors, Editors, and Publishers.

 For more detailed information, see http://www.icmje.org/.

Up to six authors:
[1] Araújo LA, Silva LR, Mendes FA. Digestive tract neural control and gastrointestinal disorders in cerebral palsy. J Pediatr (Rio J). 2012;88:455-64.

More than six authors:
[2] Ribeiro MA, Silva MT, Ribeiro JD, Moreira MM, Almeida CC, Almeida-Junior AA, et al. Volumetric capnography as a tool to detect early peripheric lung obstruction in cystic fibrosis patients. J Pediatr (Rio J). 2012;88:509-17.

Organization as author:
[3] Mercier CE, Dunn MS, Ferrelli KR, Howard DB, Soll RF; Vermont Oxford Network ELBW Infant Follow-Up Study Group. Neurodevelopmental outcome of extremely low birth weight infants from the Vermont Oxford network: 1998-2003. Neonatology. 2010;97:329-38.

No author given:
[4] Informed consent, parental permission, and assent in pediatric practice. Committee on Bioethics, American Academy of Pediatrics. Pediatrics. 1995;95:314-7.

Article published electronically ahead of the print version:
[5] Carvalho CG, Ribeiro MR, Bonilha MM, Fernandes Jr M, Procianoy RS, Silveira RC. Use of off-label and unlicensed drugs in the neonatal intensive care unit and its association with severity scores. J Pediatr (Rio J). 2012 Oct 30. [Epub ahead of print]

Books:
[6] Blumer JL, Reed MD. Principles of neonatal pharmacology. In: Yaffe SJ, Aranda JV, eds. Neonatal and Pediatric Pharmacology. 3rd ed. Baltimore: Lippincott, Williams and Wilkins; 2005. p. 146-58.

Academic studies:
[7] Borkowski MM. Infant sleep and feeding: a telephone survey of Hispanic Americans [dissertation]. Mount Pleasant, MI: Central Michigan University; 2002.

CD-ROM:
[8] Anderson SC, Poulsen KB. Anderson’s electronic atlas of hematology [CD-ROM]. Philadelphia: Lippincott Williams & Wilkins; 2002.

Homepage/website:
[9] R Development Core Team [Internet]. R: A language and environment for statistical computing. Vienna: R Foundation for Statistical Computing; 2003 [cited 2011 Oct 21]. Available from: http://www.R-project.org

Official Documents:
[10] Brazil. Ministry of Health. Department of Health Care. Department of Strategic and Programmatic Actions. Atenção à saúde do recém-nascido: guia para os profissionais de saúde: cuidados gerais. Brasília: Ministry of Health; 2011. v. 1. 192p. (Série A. Normas e Manuais Técnicos)

Presentation:
[11] Bugni VM, Okamoto KY, Ozaki LS, Teles FM, Molina J, Bueno VC, et al. Development of a questionnaire for early detection of factors associated to the adherence to treatment of children and adolescents with chronic rheumatic diseases - “the Pediatric Rheumatology Adherence Questionnaire (PRAM)”. Paper presented at the ARC/ARHP Annual Meeting; November 5-9, 2011; Chicago, IL.

 

 

Supplementary Documents

 

In order to submit the article, three different files must be sent: the title page with the data of the authors, the body of the manuscript without the identification of the authors, and a document in which the authors of the article ensure that:

a)     The article is original.
b)     It has never been published and will not be published in another journal.
c)     All authors participated in the conception of the study, the analysis and interpretation of the data and the article's writing or critical review.
d)     All authors have read and approved the final version.
e)     No information has been omitted on any links or financing agreements between the authors and companies or individuals who may be interested in the material addressed in the article.
f)      All persons who have made substantial contributions to the article but did not meet the authorship criteria are quoted in the acknowledgments, for which they have provided written authorization.
g)      Reconhecem que a Sociedade Brasileira de Pediatria passa a ter os direitos autorais quando o artigo for publicado.

 

 

 

Financing Statement

 

On the title page, it is necessary to identify who provided financial support for the research and/or preparation of the article and briefly describe the role of the sponsor(s), if any, in the study design; in the collection, analysis and interpretation of data; in the writing of the manuscript; and in the decision to send the article for publication. Example:

Funding: This work received funding from the National Institutes of Health [grant numbers xxxx, yyyy]; the Bill & Melinda Gates Foundation, Seattle, WA [grant number zzzz]; and the United States Institutes of Peace [grant number yyyy].

It is not necessary to include detailed descriptions about the program or type of funding and awards. When funding is from a block grant or other resources available to a university, college, or other research institution, submit the name of the institute or organization that provided the funding. If no funding has been provided for the research, it is recommended to include the following sentence: This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

 

 

Contact

 

Brazilian Society of Pediatrics
Av. Carlos Gomes, 328 cj. 304, Zip Code: 90480-000
Porto Alegre, RS, Brazil
Phone: (+55 51) 3108-3328
assessoria@jped.com.br

 

 

Sociedade Brasileira de Pediatria Av. Carlos Gomes, 328 cj. 304, CEP: 90480-000 , Tel.: (+55 51) 3108-3328 - Porto Alegre - RS - Brazil
E-mail: assessoria@jped.com.br